LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹26 Cr | ₹51 Cr | ₹73 Cr | ₹73 Cr | ₹149 Cr |
What is the latest Total Non-Current Liabilities ratio of LYKA LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹51 Cr |
| Mar2023 | ₹73 Cr |
| Mar2022 | ₹73 Cr |
| Mar2021 | ₹149 Cr |
How is Total Non-Current Liabilities of LYKA LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | -48.85 | |
| Mar2024 | ₹51 Cr | -30.63 | |
| Mar2023 | ₹73 Cr | 0.66 | |
| Mar2022 | ₹73 Cr | -51.12 | |
| Mar2021 | ₹149 Cr | - | |
Compare Total Non-Current Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹245.0 Cr | -0.1% | -9.1% | -48.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | 1.2% | -0.9% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 2.7% | -3.8% | 5.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.1% | -8.2% | -8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | 2.7% | 7.1% | 2.8% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -0.1% |
-9.1% |
-48.8% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses